A Partial Classical Resolution/Preparative Chiral Supercritical Fluid Chromatography Method for the Rapid Preparation of the Pivotal Intermediate in the Synthesis of Two Nonsteroidal Glucocorticoid Receptor Modulators-Reference-Cited by-同舟云学术

A Partial Classical Resolution/Preparative Chiral Supercritical Fluid Chromatography Method for the Rapid Preparation of the Pivotal Intermediate in the Synthesis of Two Nonsteroidal Glucocorticoid Receptor Modulators

Published:2016-05-11 Issue:5 Volume:20 Page:934-939
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

de Mas Nuria¹,Natalie Kenneth J.¹,Quiroz Fernando¹,Rosso Victor W.¹,Chen Doris C.¹,Conlon David A.¹

Affiliation:

1. Chemical & Synthetic Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.6b00036

Reference13 articles.

1. Synthesis, Chromatographic Purification, and Isolation of Epothilone–Folic Acid Conjugate BMS-753493

2. Simulated moving bed chromatography for the separation of enantiomers

3. Development of an Efficient Synthesis of Two CRF Antagonists for the Treatment of Neurological Disorders

4. The “VARICOL” Process: A New Multicolumn Continuous Chromatographic Process

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and applications of chiral resolution in pharmaceutical field;Chirality;2022-06-08

2. Separation, Asymmetric Synthesis and Analysis of Stereoisomers;Progress in Drug Research;2022

3. Large‐scale chiral supercritical fluid chromatography of a key intermediate in the synthesis of two S1P 1 final active pharmaceutical ingredients;SEPARATION SCIENCE PLUS;2019-09

4. Active Pharmaceutical Ingredient Cost of Goods: Discovery to Early Development;Early Drug Development;2018-08-03

5. Role of Salt Selection in Drug Discovery and Development;Dosage Form Design Considerations;2018